As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The Executive Director, Medical Affairs Strategy is responsible to ensure that Boehringer Ingelheim profiles our product(s) and prepares the market from a Medical Affairs perspective for product success, both prior to and leading up to launch as well as throughout the product lifecycle. This is done by bringing together therapeutic area landscape knowledge, US healthcare dynamics, and medical affairs experience to translate US medical needs, gaps, and value drivers into an integrated strategic plan, budget, and tactics that enables the medical affairs role in the overall Boehringer Ingelheim market approach and informs clinical development efforts where applicable.
The ED, Medical Affairs Strategy collaborates cross functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.) as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy.
Duties & Responsibilities Leads the US TA co-creation with Corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensure US strategic business needs are fully integrated into the global IBPs.Leads the implementation of the Launch Excellence in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence.Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for [X - TA] products/indications that prioritize innovation and address meaningful gaps internally and externally.Effectively leads the creation and execution medical tactics, key data release activities, stay abreast of paradigm shifts in clinical practice, and align with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare landscape.Identifies and promotes synergies throughout the product lifecycle by influencing the US TAs, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders. Proactively partners with the Clinical Development Lead and the Early Asset TA Lead to ensure the prioritized US clinical practice dynamics are fully integrated into the Clinical Development programs. Ensures success in TA launches and the timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership. Proactively collaborates very closely with the respective Clinical Development counterparts to ensure integration of US medical affairs strategic insights and market dynamics into the appropriate clinical development governance processes and decisions.Serves as leader and key representative in strategic discussions with TAs and CDMA Leadership regarding [X - TA] products to maximize business opportunities from a medical perspective, identify risks, assess the competitive landscape, and ensure appropriate collaboration occur with various business functions. Leads the integration of insights, planning, execution, and analysis of evidence programs, creation and enhancement of content resources, maximizing medical communication channels and Strategic Engagement program with key experts, scientific leaders, and key institutions. Leads and provides guidance to the team on strategic congress planning, medical education, advisory boards, publication strategies, scientific advancement grants, interface with professional societies relevant to the [X - TA] products. Leads proactive and ad hoc TA specific US projects to drive key strategic initiatives that facilitate business agility, customer focus and ensure compliance standards are met. Ensures the effectiveness of CDMA TA budget management and planning activities to strengthen digital, hybrid and omnichannel growth opportunities, ensures availability of prioritized content, as well as develops and tracks the associated agreed measurable business outcomes. Proactively engages with Medical Customer Experience, A&I, and Capability Excellence teams to ensure seamless planning.Actively contributes at and represents the CDMA TA team in internal business planning workshops and relevant strategic planning governance regarding [X - TA] products to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., key performance indicators, metrics).Requirements Advanced degree in health sciences required; Doctorate degree strongly preferred.Minimum of ten (10) years of experience within the pharmaceutical industry preferably in Medical Affairs roles.Minimum of five (5) years leading and developing people / scientific team; preferably in positions related to medical affairs strategy and operations; clinical expertise, knowledge of clinical development, and some relevant experience in the disease area within the pharmaceutical industry strongly preferred.Demonstrated experience with pharmaceutical drug development and the use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation required.Ability to collaborate, influence, and lead with executive presence, establishing strategic direction, drive execution, create compelling communications and provide a global perspective.Ability to translate scientific and medical market insights into medical tactical plans for effective launches of pharmaceutical products in the US, integrated evidence generation plans, and optimized medical strategies.Demonstrated ability to collaborate cross-functionally to enable successful execution and deliver results in a deadline-driven environment while managing multiple priorities.Deep understanding of Cardio-Renal therapeutic area(s), shifting US healthcare environment, medical, pharmaceutical and payor market dynamics, portfolio growth, and ability to manage multiple projects and identify risks in a fast-paced environment with a drive for results and sense of urgency to meet medical market needs.Ability to travel with some overnights away from home as required by the nature of the role.
Eligibility Requirements: